{"@id":"https://bioecon.ru/technology/galnac-sirna-conjugates/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://cn.bioecon.ru/technology/galnac-sirna-conjugates/","json":"https://cn.bioecon.ru/api/v1/technology/galnac-sirna-conjugates/index.json"},"id":"galnac-sirna-conjugates","industries":["pharma","biomanufacturing"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/gsk/","https://bioecon.ru/companies/jiangsu-hengrui-medicine/","https://bioecon.ru/companies/daiichi-sankyo/","https://bioecon.ru/companies/bluestem-biosciences/","https://bioecon.ru/companies/global-bioenergies/","https://bioecon.ru/companies/haesin/","https://bioecon.ru/companies/puevit-gmbh/"]},"maturity":8,"name":"靶向肝细胞的GalNAc-siRNA偶联药物技术","regions":["ch","eu","us","cn"],"risk":"low","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"三天线GalNAc靶向配体合成"},{"n":2,"title":"全化学修饰寡核苷酸固相合成"},{"n":3,"title":"皮下注射水针剂型开发"},{"n":4,"title":"单次给药半衰期超长基因静默"}],"summary":"经化学全修饰的高稳定双链小干扰RNA与三聚乙酰半乳糖胺 (GalNAc) 配体共价偶联，特异性靶向肝实质细胞去唾液酸糖蛋白受体 (ASGPR)，实现皮下注射长效基因沉默。","url":"/technology/galnac-sirna-conjugates/","verified":"2026-11-22"}